Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study

Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study

Alessandro Roggeri,1 Claudio Micheletto,2 Daniela Paola Roggeri11ProCure Solutions, Bergamo, Italy; 2Respiratory Unit, Mater Salutis Hospital, Legnago, Verona, ItalyPurpose: Fixed-dose combinations of inhaled corticosteroids and long-acting ß2-agonists have proven to prevent and reduce ch...

Full description

Bibliographic Details
Main Authors:	Roggeri A, Micheletto C, Roggeri DP
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-06-01
Series:	International Journal of COPD
Online Access:	http://www.dovepress.com/outcomes-and-costs-of-treating-chronic-obstructive-pulmonary-disease-w-a17110

Similar Items

Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues
by: Roggeri A, et al.
Published: (2016-03-01)

Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy
by: Roggeri DP, et al.
Published: (2017-09-01)

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
by: Tashkin DP, et al.
Published: (2018-06-01)

Impact of hospitalizations for bronchiolitis in preterm infants on long-term health care costs in Italy: a retrospective case-control study
by: Roggeri DP, et al.
Published: (2016-08-01)

Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
by: Tashkin DP, et al.
Published: (2018-08-01)

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
by: Roggeri DP, et al.
Published: (2015-07-01)

Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy
by: Tognella S, et al.
Published: (2021-08-01)

Inhaled Steroids in Chronic Obstructive Pulmonary Disease
by: Nick R Anthonisen
Published: (2002-01-01)

Impact of health technology assessment on prescribing patterns of inhaled fixed-dose combination triple therapy in chronic obstructive pulmonary disease
by: Jennifer Cook, et al.
Published: (2021-01-01)

Palivizumab nella profilassi del virus respiratorio sinciziale: analisi di impatto sul budget del SSN italiano
by: Daniela Roggeri
Published: (2011-07-01)

[Kovaltry® for the replacement therapy in patients with Hemophilia A]
by: Daniela Paola Roggeri, et al.
Published: (2016-06-01)

Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy
by: Daniela Paola Roggeri, et al.
Published: (2017-10-01)

Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy
by: Daniela Paola Roggeri, et al.
Published: (2014-12-01)

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
by: Asche CV, et al.
Published: (2012-03-01)

Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs
by: Alessandro Roggeri, et al.
Published: (2020-03-01)

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update
by: Dal Negro RW, et al.
Published: (2015-03-01)

Cost-Effectiveness of Combination Therapy for Chronic Obstructive Pulmonary Disease
by: Anderson Chuck, et al.
Published: (2008-01-01)

Analysis of efficacy of treatment with long active inhaled combination agents in chronic obstructive pulmonary disease patients
by: Hou Chine, et al.
Published: (2010)

Use of breath-actuated inhalers in patients with chronic obstructive pulmonary disease
by: N. N. Mescheryakova
Published: (2013-12-01)

Altered deposition of inhaled nanoparticles in subjects with chronic obstructive pulmonary disease
by: Jonas K F Jakobsson, et al.
Published: (2018-08-01)

An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
by: Sonal Singh, et al.
Published: (2010-06-01)

Adherence in Inhalation Drug among Chronic Obstructive Pulmonary Disease Patient
by: Shu-Lin Lee, et al.
Published: (2016)

Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective
by: Daniela Paola Roggeri, et al.
Published: (2020-06-01)

Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study
by: Roggeri DP, et al.
Published: (2014-12-01)

Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease
by: Panos RJ
Published: (2013-04-01)

Inhaler Technique and Adherence to Inhaled Medications among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam
by: Chau Quy Ngo, et al.
Published: (2019-01-01)

Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma
by: Jian-lan Hua, et al.
Published: (2021-09-01)

In Vitro Performance of the Wixela Inhub Inhaler Using Severe Chronic Obstructive Pulmonary Disease Patient Inhalation Profiles
by: Cooper, A., et al.
Published: (2022)

The Nurse Practitioners’ Perspective on Inhaler Education in Asthma and Chronic Obstructive Pulmonary Disease
by: Jane Scullion
Published: (2018-01-01)

Is Inhaler Technique Associated with Quality of Life in Patients with Chronic Obstructive Pulmonary Disease?
by: Shahideh Amini, PharmD, et al.
Published: (2020-01-01)

Adequacy of inhaler technique used by people with asthma or chronic obstructive pulmonary disease
by: Bang C, et al.
Published: (2013-09-01)

Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
by: Magdalena Humenberger, et al.
Published: (2018-10-01)

Inhaled corticosteroids in chronic obstructive pulmonary disease: Moving toward precision medicine
by: Ashutosh Nath Aggarwal
Published: (2019-01-01)

Vitamin D and responses to inhaled fluticasone in severe chronic obstructive pulmonary disease
by: Ken M Kunisaki, et al.
Published: (2011-01-01)

Intervention on inhalation technique of rotahaler in patients with chronic obstructive pulmonary disease and asthma
by: G.M. Khan, et al.
Published: (2016-02-01)

Effect of inhaled corticosteroids on viral and bacterial infection in chronic obstructive pulmonary disease
by: Singanayagam, Aran
Published: (2014)

Inhaled Corticosteroids Should Not Be Prescribed to All Chronic Obstructive Pulmonary Disease Patients
by: Jean Bourbeau, et al.
Published: (2003-01-01)

Evaluation of inhaler use technique among patients with chronic obstructive pulmonary disease
by: Asieh Hatefi, et al.
Published: (2021-06-01)

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
by: Tashkin DP
Published: (2020-11-01)

Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis
by: Eleanor L Axson, et al.
Published: (2020-09-01)

Cannot write session to /tmp/vufind_sessions/sess_8bcheo04b59iu2vq78p3ag71pk